跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 495 条关于
“SGLT1/SGLT2i”
全部
495
临床试验
398
药物
9
机构
1
资讯
87
去年
FDA Panel Hesitates on Sotagliflozin for Type 1 Diabetes with Chronic Kidney Disease
去年
SGLT2 Inhibitors Show Promise in Cirrhosis Patients, Reducing Complications and Mortality
去年
SGLT2 Inhibitors Show Promise in Managing Chronic Kidney Disease in Real-World Settings
去年
FDA Panel Rejects Sotagliflozin for Type 1 Diabetes with Mild-to-Moderate CKD
2个月前
Vogenx raises $81.3M in Nasdaq IPO to advance SGLT1 inhibitor mizagliflozin in metabolic disorders
7个月前
SGLT2 Inhibitors Reduce Gout Medication Burden in Patients with Type 2 Diabetes
去年
Error parsing response
去年
SGLT2 Inhibitors Linked to Increased Red Blood Cell Counts But No Thrombotic Risk in Type 2 Diabetes Patients
2年前
Sotagliflozin Improves Glycemic Control in Type 2 Diabetes Patients on Insulin Therapy
去年
Singapore Trial to Evaluate Multicomponent Intervention for Chronic Kidney Disease Management
第 1 页,共 9 页
上一页
下一页